Looks like UNS has a future, page-8

10x10 we had timelines previously, I wouldn't think 2020 is realistic for commercial sales based on their track record. IF they get to 2020 there's 2 little things they'll need to focus on in the meantime. 1. Funding and cash burn. 2. Delisting when is goes to below $1 again. Also forget $ for WI in clinical trials. The company produces and supplies as part of the "customer program".